Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic-Reference-Cited by-同舟云学术

Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic

Published:2022-11 Issue:4 Volume:2 Page:100104
ISSN:2667-0380
Container-title:Journal of Clinical Virology Plus
language:en
Short-container-title:Journal of Clinical Virology Plus

Author:

Guzmán María G,Pérez Lissette,Tejero Yahisel,Mederos Dailyn,Aguado Mirtha E.,Pintos Yanet,Valdes Odalys,Álvarez Mayling,de León Liena de Regla Ponce,Baldoquín Waldemar,Martínez Yenisleidys,Figueredo Claudia,Naranjo Celine,Nuñes Lirialys,López Almaguer Yanaris,Fernández José R de Armas,Portal Miranda José A,Kourí Vivian

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference20 articles.

1. World Health Organization. (‎2021)‎. COVID-19 weekly epidemiological update, edition 49, 20 July 2021. World Health Organization. https://apps.who.int/iris/handle/10665/343120.

2. Actualización epidemiológica: Enfermedad por Coronavirus (COVID-19). 30 de octubre de 2021;Organización Panamericana de la,2021

3. Organización Panamericana de la Salud. Cuba, a un año de la pandemia. Boletín de la OPS-OMS en Cuba. Hitos y alcance de la respuesta cubana a la COVID-19. Entrevista con el Ministro de Salud Pública, Dr. José Angel Portal. 25 (1) (2021), 4-11.

4. Evolución por días de la Tasa de Incidencia (por 100 mil);Almeida;Covid19 CubaData,2021

5. Situación de la COVID-19 en Cuba a un año de la pandemia;Borroto;Bol. de la OPS-OMS en Cuba,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients;Frontiers in Neuroscience;2024-01-08

2. A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba;Spatial and Spatio-temporal Epidemiology;2023-06

3. A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study);The Lancet Regional Health - Americas;2023-05

4. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial;The Lancet Regional Health - Americas;2023-02

5. A phase 3, randomised, double-blind, placebo-controlled clinical trial for adult evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine (ABDALA-3 Study);2022-09-10